Cardiovascular Center, Takatsu General Hospital, Kanagawa, Japan.
Diagn Interv Radiol. 2021 May;27(3):413-417. doi: 10.5152/dir.2021.20675.
Endovascular therapy has recently become acceptable for the reconstruction of below-the-knee (BTK) and below-the-ankle (BTA) arterial lesions. However, we have sometimes experienced BTK or BTA lesions with calcifications that are too severe for balloon catheters to cross or expand despite successful guidewire passage. In this study, we assessed the feasibility and safety of the novel inner PIERCE technique for breaking down the calcium burden of BTK and BTA arterial lesions.
We retrospectively reviewed the records of patients who had undergone endovascular therapy between August 2018 and December 2019. The inner PIERCE technique was performed in those cases where low-profile balloon catheters were unable to pass through the target lesions or balloon indentation did not disappear beyond the rated burst pressure. An externalized guidewire system was established in 8 cases via bidirectional approaches, and a 20-gauge needle was directly inserted through the guidewires from the distal puncture site. In 10 cases of successful antegrade wiring, the tibial or pedal arteries distal to the lesion site were punctured for a retrograde guidewire approach to the lesion. The needle was slowly rotated and advanced across the lesion.
We found that all lesions were severely calcified and 83.3% had chronic total occlusion. The inner PIERCE procedure allowed successful passage of the needle and subsequent low-profile balloon catheters in all cases. Optimal balloon dilatation was achieved in 94.4% of the cases using this technique. No procedure-related adverse events were observed.
The novel inner PIERCE technique is a safe and feasible method for disrupting calcified BTK and BTA lesions.
血管腔内治疗最近已被接受用于重建膝下(BTK)和踝下(BTA)动脉病变。然而,我们有时会遇到钙化程度过于严重的 BTK 或 BTA 病变,即使导丝能够顺利通过,也无法用球囊导管穿过或扩张。在这项研究中,我们评估了新型腔内 PIERCE 技术用于分解 BTK 和 BTA 动脉病变中钙负荷的可行性和安全性。
我们回顾性分析了 2018 年 8 月至 2019 年 12 月期间接受血管腔内治疗的患者记录。在低顺应性球囊导管无法通过目标病变或球囊压痕未超过额定爆破压的情况下,采用腔内 PIERCE 技术。通过双向入路在 8 例患者中建立外置导丝系统,并从远端穿刺部位直接通过导丝插入 20 号针。在 10 例成功顺行导丝的病例中,穿刺病变远端的胫或腓动脉,逆行导丝进入病变。缓慢旋转并推进针穿过病变。
我们发现所有病变均严重钙化,83.3%为慢性完全闭塞。腔内 PIERCE 手术允许所有病例中的针和随后的低顺应性球囊导管顺利通过。该技术可使 94.4%的病例获得最佳的球囊扩张效果。未观察到与操作相关的不良事件。
新型腔内 PIERCE 技术是一种安全可行的方法,可用于破坏钙化的 BTK 和 BTA 病变。